GMT Capital Corp

SEC CIK: 0001106191
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

AMLX holding history

Amylyx Pharmaceuticals, Inc. in every 13F filed by GMT Capital Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMLX overview All 13F holders of AMLX Full Q2 2026 holdings

Shares (Q1 2024): 0; Sold out in Q1 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2023

Holdings of AMLX by GMT Capital Corp, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2024	0	$0	0.0%	−786,000−100.0%	Sold out	Holders
Q4 2023	786,000	$11.6M	0.4%	+209,700+36.4%	Added	Holders
Q3 2023	576,300	$10.6M	0.4%	+115,300+25.0%	Added	Holders
Q2 2023	461,000	$9.94M	0.4%	+461,000	New	Holders